Repository logo
 

HNRNPH1 regulates the neuroprotective cold-shock protein RBM3 expression through poison exon exclusion.

Published version
Peer-reviewed

Repository DOI


Change log

Authors

Abstract

Enhanced expression of the cold-shock protein RNA binding motif 3 (RBM3) is highly neuroprotective both in vitro and in vivo. Whilst upstream signalling pathways leading to RBM3 expression have been described, the precise molecular mechanism of RBM3 cold induction remains elusive. To identify temperature-dependent modulators of RBM3, we performed a genome-wide CRISPR-Cas9 knockout screen using RBM3-reporter human iPSC-derived neurons. We found that RBM3 mRNA and protein levels are robustly regulated by several splicing factors, with heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) being the strongest positive regulator. Splicing analysis revealed that moderate hypothermia significantly represses the inclusion of a poison exon, which, when retained, targets the mRNA for nonsense-mediated decay. Importantly, we show that HNRNPH1 mediates this cold-dependent exon skipping via its thermosensitive interaction with a G-rich motif within the poison exon. Our study provides novel mechanistic insights into the regulation of RBM3 and provides further targets for neuroprotective therapeutic strategies.

Description

Acknowledgements: The authors thank Sandeep Rajan and Stefanie Foskolou (University of Cambridge) for technical assistance, Nina M. Rzechorzek (University of Cambridge) for insightful discussions, Mark Kotter for NGN2‐OPTi‐OX iPSC line, Oliver Muehlemann (University of Bern) for sharing the SMG1 inhibitor, Alessio Vagnoni (King's College London) for HEK293T cells, Mark McNally (Medical College of Wisconsin) for HNRNPH1 construct. Cambridge CRUK Core Genomics Facility and CIMR Flow Cytometry Core Facility for services. This work is supported by a Sir Henry Wellcome Postdoctoral Fellowship [215943/Z/19/Z] (to J.Q.L.), an Open Targets grant [OTAR2054] (to S.P., S.F.F., E.M., G.R.M.), the UK Dementia Research Institute ([UK DRI‐6005] to M.D.R), and to D.K., S.M., N.P., D.M.D.B., J.L.F., J.U., E.M., G.R.M., which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council (MRC), Alzheimer's Society and Alzheimer's Research UK.


Funder: Alzheimer's Research UK (ARUK)


Funder: Alzheimer's Society; doi: https://doi.org/10.13039/501100000320


Funder: UKRI | Medical Research Council (MRC)

Journal Title

EMBO J

Conference Name

Journal ISSN

0261-4189
1460-2075

Volume Title

42

Publisher

Springer Nature

Rights and licensing

Except where otherwised noted, this item's license is described as Attribution 4.0 International
Sponsorship
Wellcome Trust (215943/Z/19/Z)
UK Dementia Research Institute (DRICam17/18)
An Open Targets grant [OTAR2054], the UK Dementia Research Institute, which receives its funding from UK DRI Ltd, funded by the UK Medical Research Council (MRC), Alzheimer’s Society and Alzheimer’s Research UK.

Relationships

Is derived from: